Teicoplanin
Category
Small Molecule Fermentation APIs
Sub-Category
Glycopeptide Antibiotics
Description : Operating as a high-potency lipoglycopeptide antibacterial complex, teicoplanin active substance (CAS No: 61036-62-2) is synthesised via large-scale aerobic submerged fermentation of the actinobacterium Actinoplanes techomyceticus. This advanced active pharmaceutical ingredient comprises five closely related core components (A2-1 through A2-5) alongside a congener core (A3-1), each possessing a central heptapeptide backbone decorated with specific fatty-acid acyl chains. The unique lipophilic side chains anchored to its aglycone core enhance membrane binding, extending its systemic elimination half-life and conferring superior tissue penetration over traditional non-lipophilic glycopeptides. Our commercial manufacturing facility utilises 60KL high-capacity industrial fermenters integrated with automated multi-stage column chromatography and cGMP crystallisation lines to isolate the drug substance at an API assay of ≥ 99%. Global pharmaceutical formulators and hospital supply contractors source this lipoglycopeptide active ingredient to manufacture critical parenteral anti-infectives targeting methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus faecalis, and severe Gram-positive hospital-acquired infections. Biopharmaceutical procurement managers, generic drug manufacturers, and regional health authority suppliers choose our certified global teicoplanin active substance to prevent batch-to-batch ratio shifts among the five A2 sub-components, ensuring compliance with European Pharmacopoeia (Ph. Eur.) and international monograph standards. Quality assurance and regulatory compliance managers can verify teicoplanin batch-specific parameters, such as total A2 component ratio (≥ 80.0%), residual solvent thresholds, and endotoxin levels (< 0.05 EU/mg). We are an established Teicoplanin API supplier with ≥ 99% purity globally for semi-finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Teicoplanin COA/TDS/SDS. Beyond supply, we support partners with region-specific compliances, GMP quality assurance, and regulatory documentation through global supply chain capabilities and logistics coordination.






